Summit Technologies' first-quarter results boosted by US sales
This article was originally published in Clinica
Executive Summary
Summit Technologies' first-quarter sales have increased 94% compared with the previous year, mainly due to higher US sales of the company's excimer laser system. In March, the Massachusetts-based manufacturer of ophthalmic lasers received US FDA approval for its laser system for phototherapeutic keratectomy (PTK) to treat certain corneal pathologies (see Clinica No 646, p 20).